Industry / China
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
EU Cautious Over Imported APIs
October 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Calls within the European Union (EU) to tighten safety regulations for imported of active pharmaceutical ingredients (APIs) have intensified on the back of a number of scares over Chinese-produced goods. In the US, there have been a number of product recalls in recent months, ranging from food items to toys, damaging the 'Made in China'